178 related articles for article (PubMed ID: 20027676)
1. MRI versus 64-row MDCT for diagnosis of hepatocellular carcinoma.
Pitton MB; Kloeckner R; Herber S; Otto G; Kreitner KF; Dueber C
World J Gastroenterol; 2009 Dec; 15(48):6044-51. PubMed ID: 20027676
[TBL] [Abstract][Full Text] [Related]
2. MDCT versus MRI assessment of tumor response after transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Kloeckner R; Otto G; Biesterfeld S; Oberholzer K; Dueber C; Pitton MB
Cardiovasc Intervent Radiol; 2010 Jun; 33(3):532-40. PubMed ID: 19847482
[TBL] [Abstract][Full Text] [Related]
3. Small (Golfieri R; Marini E; Bazzocchi A; Fusco F; Trevisani F; Sama C; Mazzella G; Cavuto S; Piscaglia F; Bolondi L
Radiol Med; 2009 Dec; 114(8):1239-66. PubMed ID: 19697104
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of double arterial phase dynamic magnetic resonance imaging with the sensitivity encoding technique versus dynamic multidetector-row helical computed tomography for detecting hypervascular hepatocellular carcinoma.
Kumano S; Uemura M; Haraikawa T; Hirata M; Kikuchi K; Kim T; Okada M; Mochizuki T; Murakami T
Jpn J Radiol; 2009 Jul; 27(6):229-36. PubMed ID: 19626408
[TBL] [Abstract][Full Text] [Related]
5. [Small hepatocellular carcinoma in patients with hepatitis B-induced cirrhosis: a comparison between MRI and MDCT].
Jiang YY; Wang XY; Guo XM; Jiang XX
Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Dec; 42(6):767-72. PubMed ID: 21170112
[TBL] [Abstract][Full Text] [Related]
6. Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid.
Semaan S; Vietti Violi N; Lewis S; Chatterji M; Song C; Besa C; Babb JS; Fiel MI; Schwartz M; Thung S; Sirlin CB; Taouli B
Eur Radiol; 2020 Feb; 30(2):1020-1030. PubMed ID: 31673837
[TBL] [Abstract][Full Text] [Related]
7. Contrast imaging techniques to diagnose hepatocellular carcinoma in cirrhotics outside regular surveillance.
Iavarone M; Viganò M; Piazza N; Occhipinti V; Sangiovanni A; Maggioni M; D'Ambrosio G; Forzenigo LV; Motta F; Lampertico P; Rumi MG; Colombo M
Ann Hepatol; 2019; 18(2):318-324. PubMed ID: 31036496
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
Forner A; Vilana R; Ayuso C; Bianchi L; Solé M; Ayuso JR; Boix L; Sala M; Varela M; Llovet JM; Brú C; Bruix J
Hepatology; 2008 Jan; 47(1):97-104. PubMed ID: 18069697
[TBL] [Abstract][Full Text] [Related]
9. Contrast ultrasound LI-RADS LR-5 identifies hepatocellular carcinoma in cirrhosis in a multicenter restropective study of 1,006 nodules.
Terzi E; Iavarone M; Pompili M; Veronese L; Cabibbo G; Fraquelli M; Riccardi L; De Bonis L; Sangiovanni A; Leoni S; Zocco MA; Rossi S; Alessi N; Wilson SR; Piscaglia F;
J Hepatol; 2018 Mar; 68(3):485-492. PubMed ID: 29133247
[TBL] [Abstract][Full Text] [Related]
10. Detection of hypervascular hepatocellular carcinoma: Comparison of multi-detector CT with digital subtraction angiography and Lipiodol CT.
Zheng XH; Guan YS; Zhou XP; Huang J; Sun L; Li X; Liu Y
World J Gastroenterol; 2005 Jan; 11(2):200-3. PubMed ID: 15633215
[TBL] [Abstract][Full Text] [Related]
11. Validation of diagnostic criteria using gadoxetic acid-enhanced and diffusion-weighted MR imaging for small hepatocellular carcinoma (<= 2.0 cm) in patients with hepatitis-induced liver cirrhosis.
Park MJ; Kim YK; Lee MH; Lee JH
Acta Radiol; 2013 Mar; 54(2):127-36. PubMed ID: 23148300
[TBL] [Abstract][Full Text] [Related]
12. Comparison of hepatic MDCT, MRI, and DSA to explant pathology for the detection and treatment planning of hepatocellular carcinoma.
Ladd LM; Tirkes T; Tann M; Agarwal DM; Johnson MS; Tahir B; Sandrasegaran K
Clin Mol Hepatol; 2016 Dec; 22(4):450-457. PubMed ID: 27987537
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in cirrhotic patients at multidetector CT: hepatic venous phase versus delayed phase for the detection of tumour washout.
Furlan A; Marin D; Vanzulli A; Patera GP; Ronzoni A; Midiri M; Bazzocchi M; Lagalla R; Brancatelli G
Br J Radiol; 2011 May; 84(1001):403-12. PubMed ID: 21081569
[TBL] [Abstract][Full Text] [Related]
14. Additional value of gadoxetic acid-DTPA-enhanced hepatobiliary phase MR imaging in the diagnosis of early-stage hepatocellular carcinoma: comparison with dynamic triple-phase multidetector CT imaging.
Haradome H; Grazioli L; Tinti R; Morone M; Motosugi U; Sano K; Ichikawa T; Kwee TC; Colagrande S
J Magn Reson Imaging; 2011 Jul; 34(1):69-78. PubMed ID: 21598343
[TBL] [Abstract][Full Text] [Related]
15. Detection of nodules in liver cirrhosis: spiral computed tomography or magnetic resonance imaging? A prospective study of 88 nodules in 34 patients.
de Lédinghen V; Laharie D; Lecesne R; Le Bail B; Winnock M; Bernard PH; Saric J; Couzigou P; Balabaud C; Bioulac-Sage P; Drouillard J
Eur J Gastroenterol Hepatol; 2002 Feb; 14(2):159-65. PubMed ID: 11981340
[TBL] [Abstract][Full Text] [Related]
16. Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT.
Akai H; Kiryu S; Matsuda I; Satou J; Takao H; Tajima T; Watanabe Y; Imamura H; Kokudo N; Akahane M; Ohtomo K
Eur J Radiol; 2011 Nov; 80(2):310-5. PubMed ID: 20732773
[TBL] [Abstract][Full Text] [Related]
17. The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study.
Cho YZ; Park SY; Choi EH; Baik SK; Kwon SO; Kim YJ; Cha SH; Kim MY
Clin Mol Hepatol; 2015 Jun; 21(2):165-74. PubMed ID: 26157754
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Lipiodol uptake in angiography and computed tomography for the diagnosis of malignant versus benign hepatocellular nodules in cirrhotic liver.
Langenbach MC; Vogl TJ; von den Driesch I; Kaltenbach B; Scholtz JE; Hammerstingl RM; Gruber-Rouh T
Eur Radiol; 2019 Dec; 29(12):6539-6549. PubMed ID: 31236701
[TBL] [Abstract][Full Text] [Related]
19. Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma: comparison between multidetector-row CT and MR imaging.
Kim SM; Shin SS; Lee BC; Kim JW; Heo SH; Lim HS; Jeong YY
Abdom Radiol (NY); 2017 Oct; 42(10):2527-2537. PubMed ID: 28409202
[TBL] [Abstract][Full Text] [Related]
20. Characterizing Computed Tomography-Detected Arterial Hyperenhancing-Only Lesions in Patients at Risk of Hepatocellular Carcinoma: Can Non-Contrast Magnetic Resonance Imaging Be Used for Sequential Imaging?
Park SH; Kim B; Kim SY; Choi SJ; Huh J; Kim HJ; Kim KW; Lee SS
Korean J Radiol; 2020 Mar; 21(3):280-289. PubMed ID: 32090520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
